Arrowhead ARO-AAT Phase 2 Interim Results in Patients with Alpha-1 Liver Disease
PRESS RELEASE Sept. 16, 2020 Arrowhead ARO-AAT Phase 2 Interim Results in Patients with Alpha-1 Liver Disease Demonstrate Improvements in Key Parameters after Six Months of Treatment - Up to 97% reduction in intra-hepatic Z-AAT polymer - Up to 95% reduction in...
Statements on Takeda Clinical Trial (TAK-883-3001)
From the Desk of Miriam O'Day, President & CEO of the Alpha-1 Foundation: “It is with extreme disappointment that the Alpha-1 Foundation received the news that the Takeda Clinical Trial will not proceed forward at this time. The Foundation has every confidence...
BIOPHARMA LEADERS UNITE TO STAND WITH SCIENCE
Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines NEW YORK, September 8, 2020 — The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX),...
Vaccine Allocation NAS Advisory Group Letter
September 4, 2020 Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine RE: Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19...
It’s never to late to help: Read how Cathy Gould’s journey led her right back to helping others.
Tucked away under the trees at her Shelocta-area home, there’s a special place where Cathy Gould spends her days, writing poetry, reading and reflecting on the life she has now. It’s where she gathers with friends, family and community members. It’s a...
NIH Awards Multicenter Rare Disease Grant to Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
August 18, 2020 The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) has announced the award of a large rare disease grant which will focus on Alpha-1 Antitrypsin Deficiency. The grant entitled Alpha-1 Antitrypsin Disease Cohort:...
2020 John W. Walsh Translational Research Award
Nazli Khodayari, PhD receives the 2020 John W. Walsh Translational Research Award for the research grant entitled “Novel Biomarkers for Alpha-1-Antitrypsin Mediated Liver Disease in Circulating Exosomes”. This honorable award was created in October 2016 and is named...
PPTA: Letter to Secretary Azar
Dear Secretary Azar: On behalf of the Plasma Protein Therapeutics Association (PPTA), we wish to commend the Department’s efforts to increase collections of convalescent plasma as a treatment for patients diagnosed with COVID-19. As the trade association representing...
Help Us Say Thank You to Plasma Donors!
What better way for the Alpha-1 community to thank plasma donors and staff than from the heart! Let them know how the plasma-derived medications help to treat your Alpha-1 and expand awareness for the condition at the same time. The Alpha-1 Foundation is collecting...
